Pax Financial Group, LLC Novo Nordisk A S Transaction History

Pax Financial Group, LLC

$481 Million
Q1 2024

A detailed history of Pax Financial Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Pax Financial Group, LLC holds 6,642 shares of NVO stock, worth $949,673. This represents 0.18% of its overall portfolio holdings.

Number of Shares

6,642

Previous 7,208 7.85%

Holding current value

$949,673

Previous $745,000 14.36%

% of portfolio

0.18%

Previous 0.16%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $57,794 - $76,930	-566 Reduced 7.85%	6,642 $852,000
Q4 2023 Feb 12, 2024	SELL	$87.78 - $105.45 $20,364 - $24,464	-232 Reduced 3.12%	7,208 $745,000
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $320,654 - $703,578	3,526 Added 90.09%	7,440 $676,000
Q2 2023 Jul 18, 2023	SELL	$155.98 - $172.65 $12,790 - $14,157	-82 Reduced 2.05%	3,914 $633,000
Q1 2023 May 11, 2023	SELL	$132.34 - $159.14 $98,328 - $118,241	-743 Reduced 15.68%	3,996 $635,000

Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $163,259 - $215,445	-1,592 Reduced 25.15%	4,739 $641,000
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $11,147 - $13,680	-117 Reduced 1.81%	6,331 $631,000
Q2 2022 Aug 09, 2022	SELL	$103.24 - $121.81 $302,183 - $356,537	-2,927 Reduced 31.22%	6,448 $719,000
Q1 2022 May 10, 2022	SELL	$93.1 - $112.54 $49,063 - $59,308	-527 Reduced 5.32%	9,375 $1.04 Million
Q4 2021 Feb 07, 2022	SELL	$95.88 - $117.08 $56,377 - $68,843	-588 Reduced 5.61%	9,902 $1.11 Million
Q3 2021 Oct 29, 2021	SELL	$84.42 - $106.62 $36,131 - $45,633	-428 Reduced 3.92%	10,490 $1.01 Million
Q2 2021 Aug 13, 2021	BUY	$67.66 - $84.76 $43,776 - $54,839	647 Added 6.3%	10,918 $915,000
Q1 2021 May 10, 2021	BUY	$67.06 - $75.82 $122,049 - $137,992	1,820 Added 21.54%	10,271 $692,000
Q4 2020 Feb 03, 2021	BUY	$63.89 - $73.8 $23,064 - $26,641	361 Added 4.46%	8,451 $590,000
Q3 2020 Nov 12, 2020	BUY	$63.69 - $70.22 $61,970 - $68,324	973 Added 13.67%	8,090 $562,000
Q2 2020 Jul 31, 2020	BUY	$58.54 - $67.94 $45,953 - $53,332	785 Added 12.4%	7,117 $466,000
Q1 2020 Apr 28, 2020	BUY	$49.46 - $64.78 $72,013 - $94,319	1,456 Added 29.86%	6,332 $411,000
Q4 2019 Feb 21, 2020	BUY	$49.86 - $58.26 $243,117 - $284,075	4,876 New	4,876 $313,000

Others Institutions Holding NVO

# of Institutions

1,856

Shares Held

309M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $323B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pax Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pax Financial Group, LLC with notifications on news.

Account

Pax Financial Group, LLC Novo Nordisk A S Transaction History